Clinical trial
Unilateral Bevacizumab for Bilateral Diabetic Macular Edema
NCT00496405 · Asociación para Evitar la Ceguera en México, Other · Withdrawn
Key facts
| NCT number | NCT00496405 |
|---|---|
| Title | Unilateral Bevacizumab for Bilateral Diabetic Macular Edema |
| Official title | The Role of Unilateral Intravitreal Bevacizumab (Avastin), for the Treatment of Bilateral Diabetic Macular Edema: a Pilot Study. |
| Lead sponsor | Asociación para Evitar la Ceguera en México, Other |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetic Macular Edema, Diabetic Retinopathy |
| Intervention type | Drug |
| Interventions | bevacizumab |
| Enrollment | 0 |
| Start date | Apr 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Jul 4, 2007 |
| Last update posted | Jun 5, 2024 |
| Countries | Mexico |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: